A Controlled Trial of Taractan in Chronic Schizophrenia
1963 ◽
Vol 109
(460)
◽
pp. 418-421
◽
Keyword(s):
The purpose of this trial was to evaluate the drug Taractan in the treatment of chronic schizophrenia.Taractan (chlorprothixene) is chemically α-2-chloro-9-(w-dimethylamino propylidene)-thioxanthene. It is claimed to have neuroleptic and tranquillizing properties as well as thymoleptic activity. It is also claimed to be relatively free from side-effects. This property facilitated its use in a double-blind study.
2017 ◽
Vol 4
(1)
◽
pp. 45
Keyword(s):
1984 ◽
Vol 145
(3)
◽
pp. 294-299
◽
Keyword(s):
1985 ◽
Vol 147
(3)
◽
pp. 306-309
◽
Keyword(s):
2001 ◽
Vol 11
◽
pp. S294
◽
Keyword(s):
2002 ◽
Vol 12
◽
pp. 309-310
◽
Keyword(s):
1981 ◽
Vol 9
(3)
◽
pp. 199-202
◽
Keyword(s):
1968 ◽
Vol 20
(03/04)
◽
pp. 583-587
◽
Keyword(s):
Keyword(s):